Dr. Noriyuki Kasahara of UCSF has received $11.8 million from CIRM to target newly diagnosed high‑grade gliomas. These aggressive brain and spinal cord cancers are extremely hard to treat. The grant supports research on DB107, formerly Toca 511, an innovative gene therapy that selectively targets tumor cells. The therapy delivers an enzyme that converts a … Continue reading Gene therapy trial tests cancer-killing virus in brain tumors
UC San Francisco
Update on SCID patient enrolled in CIRM-funded gene therapy trial
Photo credit: UCSF Hataalii Tiisyatonii Begay (HT) is paving the road for newborns with SCID. When HT was born in 2018 in a remote part of the Navajo Nation, he was quickly diagnosed with a rare and -usually fatal- condition. Today, thanks to a therapy developed at UCSF and funded by CIRM, he’s a healthy … Continue reading Update on SCID patient enrolled in CIRM-funded gene therapy trial
Myocarditis in Cancer Patients Is Driven by Specific Immune Cells
In a new study, researchers from UC San Francisco and Vanderbilt University Medical Center have identified specific immune cells that cause a potentially lethal heart inflammation -called myocarditis- in a small fraction of patients treated with powerful cancer immunotherapy drugs. Myocarditis is inflammation of the heart muscle. It can cause chest pain, shortness of breath, … Continue reading Myocarditis in Cancer Patients Is Driven by Specific Immune Cells
The long road to developing a therapy for epilepsy
THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST Good science takes time. That’s an essential guiding principle for researchers, but a frustrating reality for patients who need help now. CIRM-funded epilepsy research That point was clear when the CIRM Board voted to invest nearly $8 million to test a new approach for drug‑resistant epilepsy. … Continue reading The long road to developing a therapy for epilepsy
CIRM-Funded Study of Deadly Immune Disorder Gets Boost from FDA
Hataalii Begay, age 4, first child treated with UCSF gene therapy for Artemis-SCID When Hataalii Begay was born in a remote part of the Navajo nation he was diagnosed with a rare, usually fatal condition, Artemis-SCID. New stem cell therapy Today, thanks to a therapy developed at UCSF and funded by CIRM, he's a normal healthy … Continue reading CIRM-Funded Study of Deadly Immune Disorder Gets Boost from FDA
National Academy of Medicine honors CIRM Grantees
As someone who doesn’t always send birthday cards on time, I’m used to offering belated congratulations. So I have no shame in sending them now to four CIRM grantees elected to the National Academy of Medicine in 2020. I say four, but it’s really three and a half. I’ll explain why in a moment. Being … Continue reading National Academy of Medicine honors CIRM Grantees
SPARK Students Show the Future of Science is in Good Hands
Dr. Kelly Shepard, SPARK program director The past year tested us all. The pandemic changed how we work, learn, and connect. Yet it also revealed something encouraging: the next generation of scientists is ready to meet challenges head-on. We saw that firsthand during CIRM's SPARK Conference. SPARK, or the Summer Program to Accelerate Regenerative Medicine … Continue reading SPARK Students Show the Future of Science is in Good Hands
Gene Therapy Brings New Hope for Children With AADC Deficiency
Image showing target areas for AADC gene insertion: Courtesy UCSF Most people have never heard of AADC deficiency. For the few families affected, that is a blessing. AADC deficiency is a rare genetic disorder that affects about 135 children worldwide. The disease severely disrupts brain function and development. Children with AADC deficiency often cannot speak, … Continue reading Gene Therapy Brings New Hope for Children With AADC Deficiency
CIRM Awards $14.5 Million for Three CAR T-cell Cancer Projects
CIRM’s governing board awarded $14.5 million to advance three promising cancer therapies toward clinical testing. All three projects use CAR-based cell therapy. This approach modifies a patient’s immune cells to recognize and destroy cancer cells. Moving Therapies Toward Patients The awards support translational-stage research projects through CIRM’s TRAN1 program. These projects focus on early development … Continue reading CIRM Awards $14.5 Million for Three CAR T-cell Cancer Projects
CIRM Invests $8.5 Million in Education and Clinical Trial Infrastructure
The California Institute for Regenerative Medicine (CIRM) governing board approved $8.5 million to support two important programs. The funding will continue the Summer Program to Accelerate Regenerative Medicine Knowledge (SPARK) and the Alpha Stem Cell Clinics (ASCC) Network. Together, these programs help prepare future scientists and advance stem cell and gene therapy clinical trials. SPARK … Continue reading CIRM Invests $8.5 Million in Education and Clinical Trial Infrastructure